HROW
Harrow Health, Inc. NASDAQ Listed Sep 28, 2007$42.41
Pre-mkt
$42.00
-0.97%
Mkt Cap $1.6B
52w Low $29.03
51.9% of range
52w High $54.80
50d MA $36.77
200d MA $41.21
P/E (TTM)
—
EV/EBITDA
55.0x
P/B
29.9x
Debt/Equity
4.8x
ROE
-9.8%
P/FCF
36.3x
RSI (14)
76.00
ATR (14)
$2.15
Beta
0.31
50d MA
$36.77
200d MA
$41.21
Avg Volume
1.0M
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company that focuses on development and commercialization of therapeutics for ocular surface diseases; Melt Pharmaceuticals, Inc., a clinical-stage pharmaceutical company that focused on the development and commercialization of proprietary non-intravenous, sedation, and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings; and Eton Pharmaceuticals, Inc., a commercial-stage pharmaceutical company that engages in developing and commercializing drug products. Harrow Health, Inc. owns royalty rights in four clinical stage drug candidates being developed by Surface Ophthalmics, Inc. and Melt Pharmaceuticals, Inc. The company was formerly known as Imprimis Pharmaceuticals, Inc. and changed its name to Harrow Health, Inc. in December 2018. Harrow Health, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
102 Woodmont Boulevard · Nashville, TN 37205 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | AMC | 0.40 | 0.26 | -35.0% | 53.59 | -16.7% | -28.0% | +1.6% | -7.8% | +0.5% | -3.3% | — |
| Nov 10, 2025 | AMC | 0.22 | 0.33 | +50.0% | 34.14 | -0.4% | +13.5% | -0.8% | -1.4% | +7.7% | -1.2% | — |
| Aug 11, 2025 | AMC | 0.31 | 0.24 | -23.4% | 33.74 | +6.7% | +3.2% | +4.8% | +9.6% | -3.0% | -1.3% | — |
| May 8, 2025 | AMC | 0.02 | -0.38 | -2000.0% | 23.59 | -8.9% | +3.4% | +9.3% | -1.5% | -4.3% | +1.9% | — |
| Mar 27, 2025 | AMC | 0.11 | 0.25 | +127.3% | 27.87 | +8.3% | -6.0% | +1.5% | -6.1% | +4.3% | -7.6% | — |
| Nov 13, 2024 | AMC | -0.05 | -0.12 | -140.0% | 51.80 | -19.4% | -17.3% | -9.0% | -2.7% | +4.6% | +6.9% | — |
| Aug 7, 2024 | AMC | -0.25 | -0.13 | +48.0% | 21.98 | +43.2% | +54.3% | +6.0% | -1.2% | +6.6% | -2.1% | — |
| May 13, 2024 | AMC | -0.25 | -0.28 | -12.0% | 12.07 | +20.5% | +34.5% | -1.9% | +1.4% | +3.7% | +0.2% | — |
| Mar 19, 2024 | AMC | -0.05 | -0.27 | -455.6% | 10.65 | -11.5% | -1.2% | +0.6% | +8.7% | +4.3% | +4.8% | — |
| Nov 13, 2023 | AMC | -0.02 | -0.09 | -467.5% | 12.83 | -24.4% | -36.0% | -1.3% | +6.2% | +4.2% | +5.6% | — |
| Aug 9, 2023 | AMC | -0.01 | -0.02 | -250.4% | 19.80 | +1.3% | -15.5% | +1.1% | +2.1% | -0.5% | -1.1% | — |
| May 11, 2023 | AMC | -0.06 | -0.03 | +50.0% | 27.07 | -8.8% | -18.6% | -5.2% | +0.7% | +2.7% | -3.1% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 17 | BTIG | Maintains | Buy → Buy | — | $40.65 | $41.16 | +1.3% | +2.1% | -2.4% | -2.6% | -0.8% | -1.0% |
| Apr 7 | B. Riley Securities | Maintains | Buy → Buy | — | $35.13 | $34.51 | -1.8% | +0.9% | +3.7% | +1.5% | -3.6% | +3.3% |
| Mar 19 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $34.48 | $34.00 | -1.4% | -0.2% | -3.3% | +2.2% | +3.5% | +3.3% |
| Mar 18 | BTIG | Maintains | Buy → Buy | — | $35.23 | $35.02 | -0.6% | -2.1% | -0.2% | -3.3% | +2.2% | +3.5% |
| Mar 4 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $38.60 | $39.31 | +1.8% | +1.6% | -7.8% | +0.5% | -3.3% | +2.6% |
| Mar 4 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $38.60 | $39.31 | +1.8% | +1.6% | -7.8% | +0.5% | -3.3% | +2.6% |
| Nov 12 | Ladenburg Thalmann | Maintains | Buy → Buy | — | $38.74 | $38.58 | -0.4% | -0.8% | -1.4% | +7.7% | -1.2% | -1.4% |
| Nov 12 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $38.74 | $38.58 | -0.4% | -0.8% | -1.4% | +7.7% | -1.2% | -1.4% |
| Oct 1 | B. Riley Securities | Maintains | Buy → Buy | — | $48.18 | $48.03 | -0.3% | +0.4% | -1.3% | -4.8% | -7.2% | -0.6% |
| Sep 29 | Lake Street | Maintains | Buy → Buy | — | $47.10 | $49.54 | +5.2% | +2.8% | -0.5% | +0.4% | -1.3% | -4.8% |
| Sep 29 | BTIG | Maintains | Buy → Buy | — | $47.10 | $49.54 | +5.2% | +2.8% | -0.5% | +0.4% | -1.3% | -4.8% |
| Sep 29 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $47.10 | $49.54 | +5.2% | +2.8% | -0.5% | +0.4% | -1.3% | -4.8% |
| Sep 24 | BTIG | Maintains | Buy → Buy | — | $48.85 | $48.50 | -0.7% | -2.0% | -3.6% | +2.1% | +2.8% | -0.5% |
| Sep 23 | Craig-Hallum | Maintains | Buy → Buy | — | $46.09 | $47.33 | +2.7% | +6.0% | -2.0% | -3.6% | +2.1% | +2.8% |
| Sep 23 | B. Riley Securities | Maintains | Buy → Buy | — | $46.09 | $47.33 | +2.7% | +6.0% | -2.0% | -3.6% | +2.1% | +2.8% |
| Sep 23 | BTIG | Maintains | Buy → Buy | — | $46.09 | $47.33 | +2.7% | +6.0% | -2.0% | -3.6% | +2.1% | +2.8% |
| Aug 14 | BTIG | Maintains | Buy → Buy | — | $36.50 | $36.81 | +0.8% | +9.6% | -3.0% | -1.3% | -0.2% | +0.0% |
| Aug 13 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $34.83 | $35.98 | +3.3% | +4.8% | +9.6% | -3.0% | -1.3% | -0.2% |
| May 12 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $24.40 | $24.50 | +0.4% | +9.3% | -1.5% | -4.3% | +1.9% | +10.9% |
| Apr 1 | B. Riley Securities | Maintains | Buy → Buy | — | $26.60 | $26.25 | -1.3% | -6.1% | +4.3% | -7.6% | -2.2% | -1.8% |
| Mar 31 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $26.21 | $25.52 | -2.6% | +1.5% | -6.1% | +4.3% | -7.6% | -2.2% |
| Mar 18 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $23.32 | $28.93 | +24.1% | +15.7% | +1.1% | +3.0% | +1.1% | +5.6% |
| Oct 4 | Lake Street | Maintains | Buy → Buy | — | $49.75 | $50.94 | +2.4% | +1.2% | +0.5% | +0.7% | -0.0% | -2.6% |
| Oct 4 | Craig-Hallum | Maintains | Buy → Buy | — | $49.75 | $50.94 | +2.4% | +1.2% | +0.5% | +0.7% | -0.0% | -2.6% |
| Aug 29 | B. Riley Securities | Maintains | Buy → Buy | — | $39.56 | $39.94 | +1.0% | -0.8% | +3.1% | -2.1% | -0.9% | +1.9% |
| Aug 9 | Craig-Hallum | Maintains | Buy → Buy | — | $33.92 | $34.40 | +1.4% | +6.0% | -1.2% | +6.6% | -2.1% | +5.0% |
| Aug 9 | B. Riley Securities | Maintains | Buy → Buy | — | $33.92 | $34.40 | +1.4% | +6.0% | -1.2% | +6.6% | -2.1% | +5.0% |
| Jun 21 | Craig-Hallum | Maintains | Buy → Buy | — | $19.93 | $20.05 | +0.6% | +5.4% | +2.3% | +0.7% | -1.4% | -1.6% |
| Jun 3 | Lake Street | Maintains | Buy → Buy | — | $17.95 | $18.18 | +1.3% | -5.1% | +2.2% | +2.9% | +0.2% | +1.2% |
| May 15 | Craig-Hallum | Maintains | Buy → Buy | — | $16.24 | $16.56 | +2.0% | -1.9% | +1.4% | +3.7% | +0.2% | -1.8% |
| May 15 | B. Riley Securities | Maintains | Buy → Buy | — | $16.24 | $16.56 | +2.0% | -1.9% | +1.4% | +3.7% | +0.2% | -1.8% |
| Mar 22 | B. Riley Securities | Maintains | Buy → Buy | — | $10.58 | $10.58 | +0.0% | +8.7% | +4.3% | +4.8% | +1.2% | +3.9% |
| Jul 20 | B. Riley Securities | Maintains | Buy → Buy | — | $21.53 | $22.18 | +3.0% | -1.1% | +2.2% | -2.3% | -0.1% | +0.3% |
| Apr 17 | Lake Street | Maintains | Buy → Buy | — | $21.94 | $22.98 | +4.7% | +6.0% | +1.7% | -0.6% | +1.3% | +3.5% |
| May 20 | B. Riley Securities | Maintains | Buy → Buy | — | $5.77 | $5.91 | +2.4% | +2.3% | +16.8% | -10.7% | +5.7% | +4.9% |
| Jul 2 | Ladenburg Thalmann | Maintains | Buy → Buy | — | $9.09 | $9.53 | +4.8% | +1.2% | -6.3% | -1.9% | +1.2% | -1.5% |
| Apr 7 | B. Riley FBR | Maintains | Buy → Buy | — | $3.91 | $4.12 | +5.4% | +0.3% | +1.0% | +3.3% | +3.9% | +7.5% |
| Apr 7 | B. Riley Securities | Maintains | Buy → Buy | — | $3.91 | $4.12 | +5.4% | +0.3% | +1.0% | +3.3% | +3.9% | +7.5% |
| Mar 16 | B. Riley Securities | Maintains | Buy → Buy | — | $4.98 | $4.25 | -14.7% | -21.1% | -1.5% | -7.8% | +3.6% | -0.3% |
| Mar 16 | B. Riley FBR | Maintains | Buy → Buy | — | $4.98 | $4.25 | -14.7% | -21.1% | -1.5% | -7.8% | +3.6% | -0.3% |
| Dec 10 | Lake Street | Maintains | Buy → Buy | — | $4.94 | $4.94 | +0.0% | +9.9% | +9.6% | +2.7% | -2.6% | -2.0% |
| Nov 28 | Rodman & Renshaw | Maintains | Buy → Buy | — | $2.61 | $2.68 | +2.7% | +12.6% | -5.8% | -1.8% | -4.4% | -2.3% |
| Jul 23 | Sterne Agee CRT | Maintains | Buy → Buy | — | $8.47 | $8.50 | +0.4% | -0.5% | -3.0% | -1.0% | +0.2% | -3.6% |
| Dec 16 | Craig-Hallum | Maintains | Buy → Buy | — | $8.05 | $8.09 | +0.5% | +5.6% | -0.5% | +0.4% | -2.2% | -3.6% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 18, 2026 | SILVERNAIL LAUREN PDir | — | Buy | 1,000 | $31.00 | $31K | 1,000 | +0.59% | +0.76% |
| May 18, 2026 | Graves Adrienne LDir | — | Buy | 1,000 | $31.07 | $31K | 1,000 | +0.59% | +0.76% |
| May 14, 2026 | BAUM MARK LDir/Off | CHIEF EXECUTIVE OFFICER | Buy | 10,000 | $30.20 | $302K | 2,996,130 | -0.99% | +0.12% |
| May 14, 2026 | BOLL ANDREW R.Off | PRESIDENT AND CFO | Buy | 3,500 | $29.90 | $105K | 814,679 | -0.99% | +0.12% |
8-K
Harrow Health, Inc. -- 8-K Filing
I cannot provide a meaningful analysis because the filing summary contains only administrative information (company address, incorporation details) without describing any substantive business event or transaction relevant to investors.
Jun 22
8-K · 7.01
! Medium
Harrow Health, Inc. -- 8-K 7.01: Regulation FD Disclosure
Jun 3
8-K · 1.01
!! High
Unknown — 8-K 1.01: Material Agreement
HROW signed a material agreement with BTIG (a major investment bank), likely indicating a capital raise, M&A advisory, or strategic partnership that could significantly impact the company's growth trajectory and stock valuation.
Mar 27
8-K · 8.01
!! High
Unknown — 8-K 8.01: Material Event / Announcement
Harrow priced a confidential offering on March 24, 2026, likely raising capital that dilutes existing shareholders but provides cash for operations or growth investments.
Mar 24
8-K · 8.01
!! High
Unknown — 8-K 8.01: Material Event / Announcement
HROW abandoned a planned securities offering, eliminating dilution risk and signaling management's confidence in current valuation or preference to preserve shareholder equity.
Mar 24
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
HROW's Regulation FD disclosure suggests management communicated material information to investors outside normal channels, requiring public disclosure to prevent selective information advantage.
Mar 10
8-K · 7.01
! Medium
Harrow, Inc. -- 8-K 7.01: Regulation FD Disclosure
Harrow, Inc. disclosed an investor presentation for use at conferences and meetings, providing updated information about the company's business and strategy to potential investors.
Mar 2
8-K · 5.02
!!! Very High
Harrow, Inc. -- 8-K 5.02: Executive Change
Patrick W. Sullivan's appointment as Chief Commercial Officer at Harrow, Inc. strengthens the company's commercial leadership and may improve revenue growth and market positioning.
Feb 2
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Opaleye Management Inc. | 3,905,000 | $191M | — | Dec 2025 |
| 2 | Vanguard Capital Management Llc | 1,403,056 | $49M | New | Mar 2026 |
| 3 | Morgan Stanley | 467,510 | $23M | Added | Dec 2025 |
| 4 | Marshall Wace, Llp | 644,918 | $23M | Added | Mar 2026 |
| 5 | Rice Hall James & Associates, Llc | 361,998 | $18M | Added | Dec 2025 |
| 6 | Susquehanna International Group, Llp | 457,782 | $16M | Added | Mar 2026 |
| 7 | Braidwell Lp | 295,291 | $14M | Reduced | Dec 2025 |
| 8 | Jane Street Group, Llc | 239,265 | $12M | Added | Dec 2025 |
| 9 | Northern Trust Corp | 296,865 | $10M | Reduced | Mar 2026 |
| 10 | Vanguard Portfolio Management Llc | 288,875 | $10M | New | Mar 2026 |
| 11 | Citadel Advisors Llc | 221,258 | $8M | Reduced | Mar 2026 |
| 12 | Westside Investment Management, Inc. | 185,926 | $7M | Added | Mar 2026 |
| 13 | Ubs Group Ag | 175,324 | $6M | Reduced | Mar 2026 |
| 14 | Blackhawk Capital Partners, Llc | 172,332 | $6M | Added | Mar 2026 |
| 15 | 12th Street Asset Management Company, Llc | 168,731 | $6M | Added | Mar 2026 |
| 16 | First Trust Advisors Lp | 154,096 | $5M | Added | Mar 2026 |
| 17 | Firstwave Capital Management Llc | 143,923 | $5M | Added | Mar 2026 |
| 18 | Woodmont Investment Counsel Llc | 110,559 | $4M | Added | Mar 2026 |
| 19 | Bank Of America Corp /de/ | 94,578 | $3M | Reduced | Mar 2026 |
| 20 | Steward Partners Investment Advisory, Llc | 90,629 | $3M | Added | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$1.56B
Enterprise Value
$1.73B
P/E (TTM)
—
Forward P/E
89.99x
PEG Ratio
4.91x
P/B
29.93x
P/S
5.80x
P/FCF
36.28x
EV/EBITDA
54.96x
Shares Out
36.8M
Financials (TTM)
Revenue
$268.7M
Net Income
-$15.0M
EBITDA
$31.5M
Free Cash Flow
$43.0M
Op Cash Flow
$43.9M
EPS Basic
$-0.14
EPS Diluted
$-0.40
EPS Forward
$0.47
Gross Margin
74.1%
Op Margin
10.5%
Net Margin
-5.6%
Balance Sheet
Total Assets
$399.5M
Total Liab.
$347.4M
Total Equity
$52.1M
Cash
$72.9M
LT Debt
$243.2M
Book Value/Sh
$1.42
Debt/Equity
4.80x
Current Ratio
2.20
Quick Ratio
2.06
Returns & Growth
ROE
-9.8%
ROA
-1.3%
ROIC
12.0%
Rev Growth YoY
+36.4%
EPS Growth YoY
+71.4%
Price Returns
2W
+14.1%
1M
-13.1%
3M
-35.0%
6M
-15.7%
12M
+25.3%
Technicals
52W High
$54.80
52W Low
$29.03
50d MA
$36.77
200d MA
$41.21
RSI (14)
76.00
ATR (14)
$2.15
Beta
0.31
Avg Volume
1.0M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$75.67
High
$94.00
Low
$63.00
Median
$70.00
Data updated apr 25, 2026 2:02pm
· Source: financialmodelingprep.com